🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these accounts privately for source information, while also receiving discount codes.

Active Trade on Social Networks

Separately, a robust market exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and claims of rapid British shipping. Sellers promote the substance there before directing buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Concerns

However, doctors and chemists have warned that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could lead to individuals administering substances of unknown origin.

Several experts stated the popularity for the experimental drug could be linked to the increasing price of licensed slimming products such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.

Several influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.

Platform Response and Content Removal

Based on TikTok, the platform has taken down problematic material and prohibited related keywords and search suggestions. The company said it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.

Online Marketplace Activities

Research also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with numerous of users, populated with images of weight loss, glowing testimonials and detailed guides for preparing or injecting at residence.

After moments of entering one community, a seller posted contact information, where most purchases occur. The vendor provided an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Details and Costs

Within these groups, posts display dark colored packages with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how much time a pen should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service said it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is valid, these online versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for authorized slimming medications such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has previously seen individuals harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company investigational product not yet approved … may subject patients to possibly serious health risks”.